Nisa Investment Advisors, LLC Blueprint Medicines Corp Transaction History

Nisa Investment Advisors, LLC

$16.7 Billion
Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,893 shares of BPMC stock, worth $180,024. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,893

Previous 2,041 7.25%

Holding current value

$180,024

Previous $219,000 20.09%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$84.1 - $120.5 $12,446 - $17,834	-148 Reduced 7.25%	1,893 $175,000
Q2 2024 Jul 19, 2024	BUY	$85.18 - $108.78 $4,259 - $5,439	50 Added 2.51%	2,041 $219,000
Q1 2024 May 01, 2024	BUY	$73.17 - $99.79 $3,731 - $5,089	51 Added 2.63%	1,991 $188,000
Q4 2023 Jan 25, 2024	SELL	$43.96 - $92.84 $3,956 - $8,355	-90 Reduced 4.43%	1,940 $178,000
Q2 2023 Aug 11, 2023	BUY	$42.2 - $66.37 $17,935 - $28,207	425 Added 26.48%	2,030 $128,000
Q1 2023 May 02, 2023	BUY	$37.97 - $50.0 $37,324 - $49,150	983 Added 158.04%	1,605 $72,000
Q4 2022 Feb 02, 2023	SELL	$41.06 - $66.48 $369 - $598	-9 Reduced 1.43%	622 $27,000
Q3 2022 Nov 07, 2022	SELL	$49.93 - $77.7 $2,646 - $4,118	-53 Reduced 7.75%	631 $33,000
Q2 2022 Aug 03, 2022	BUY	$45.23 - $70.15 $10,402 - $16,134	230 Added 50.66%	684 $35,000
Q1 2022 Apr 29, 2022	SELL	$54.1 - $110.08 $157,647 - $320,773	-2,914 Reduced 86.52%	454 $29,000
Q4 2021 Feb 03, 2022	BUY	$94.25 - $115.99 $96,606 - $118,889	1,025 Added 43.75%	3,368 $260,000
Q3 2021 Oct 18, 2021	SELL	$80.98 - $109.47 $146,816 - $198,469	-1,813 Reduced 43.62%	2,343 $241,000
Q4 2020 Jan 25, 2021	BUY	$92.08 - $124.48 $215,098 - $290,785	2,336 Added 128.35%	4,156 $466,000
Q3 2020 Oct 20, 2020	BUY	$66.45 - $92.7 $90,372 - $126,072	1,360 Added 295.65%	1,820 $169,000
Q2 2020 Jul 27, 2020	BUY	$57.09 - $79.27 $5,138 - $7,134	90 Added 24.32%	460 $36,000
Q1 2020 Apr 17, 2020	SELL	$48.11 - $82.22 $4,329 - $7,399	-90 Reduced 19.57%	370 $22,000
Q4 2019 Jan 17, 2020	BUY	$66.73 - $82.59 $12,011 - $14,866	180 Added 64.29%	460 $37,000
Q3 2019 Oct 17, 2019	BUY	$72.9 - $101.41 $5,832 - $8,112	80 Added 40.0%	280 $21,000
Q1 2018 Apr 10, 2018	SELL	$73.28 - $102.95 $7,328 - $10,295	-100 Reduced 33.33%	200 $18,000
Q3 2017 Oct 13, 2017	BUY	$42.37 - $69.67 $12,711 - $20,901	300	300 $21,000

Others Institutions Holding BPMC

# of Institutions

352

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.68B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Blueprint Medicines Corp Transaction History